Critical Care Medicine Doctors in Wilmington, NC Accepting Medicare

4 Critical Care Medicine doctors found. Showing 1 - 4

Dr. Thaddeus Leland Dunn, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1090 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-3345    Fax: 910-343-1924

Dr. Oluwole Ademola Odunusi, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1090 Medical Center Dr, Wilmington, NC 28401 Phone: 910-662-8550    Fax: 910-343-1924

Dr. William Giles Allen, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1090 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-3345    Fax: 910-343-1924

Dr. Brian Jan Gilmore, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1090 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-3345    Fax: 910-343-1924

News Archive

Scientists receive £265,000 to investigate link between vascular dementia and heart disease

Scientists from the University of Sheffield and University of Manchester have been awarded £265,000 from the British Heart Foundation, to investigate the links between vascular dementia and heart disease, and test whether a drug currently used to treat arthritis could also be used as a treatment for vascular dementia.

Nature Genetics publishes results from whole genome-wide study of recurrent HBV integration in HCC

The Asian Cancer Research Group (ACRG)—an independent, not-for-profit company established by Eli Lilly and Company, Merck (known as MSD outside the United States and Canada) and Pfizer Inc.—in collaboration with BGI—the world's largest genomics organization—today announced the publication of results from a whole genome-wide study of recurrent hepatitis B virus (HBV) integration in hepatocellular carcinoma (HCC) in Nature Genetics.

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration of the anticoagulant medication bivalirudin enhanced safety and efficacy compared to the use of heparin + GPIIb/IIIa inhibitors.

Study reveals impact of TP53 gene mutations on MDS severity

Considered the "guardian of the genome," TP53 is the most commonly mutated gene in cancer. TP53's normal function is to detect DNA damage and prevent cells from passing this damage on to daughter cells.

Read more Medical News

› Verified 9 days ago